Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	mismatched DNA binding	PMS1 PMS2 MSH6	5.22e-05	14	107	3	GO:0030983
GeneOntologyMolecularFunction	ATP-dependent DNA damage sensor activity	PMS1 PMS2 MSH6	1.60e-04	20	107	3	GO:0140664
GeneOntologyMolecularFunction	single base insertion or deletion binding	PMS2 MSH6	1.69e-04	4	107	2	GO:0032138
GeneOntologyMolecularFunction	DNA damage sensor activity	PMS1 PMS2 MSH6	2.79e-04	24	107	3	GO:0140612
GeneOntologyMolecularFunction	DNA insertion or deletion binding	PMS2 MSH6	4.21e-04	6	107	2	GO:0032135
GeneOntologyMolecularFunction	extracellular matrix structural constituent	HSPG2 COL12A1 FN1 LAMB1 IGFBP7 MUC6	5.29e-04	188	107	6	GO:0005201
GeneOntologyCellularComponent	mismatch repair complex	PMS1 PMS2 MSH6	2.27e-05	11	110	3	GO:0032300
GeneOntologyCellularComponent	MutLalpha complex	PMS1 PMS2	8.20e-05	3	110	2	GO:0032389
GeneOntologyCellularComponent	histone locus body	ICE1 ELL	1.64e-04	4	110	2	GO:0035363
HumanPheno	Neoplasm of the respiratory system	PMS1 PMS2 PDGFRB NSD1 MUC5B MSH6	1.01e-05	78	34	6	HP:0100606
HumanPheno	Shoulder flexion contracture	HSPG2 COL12A1 JAG2	2.22e-05	9	34	3	HP:0003044
HumanPheno	Salivary gland neoplasm	PMS1 PMS2 MSH6	3.16e-05	10	34	3	HP:0100684
HumanPheno	Laryngeal carcinoma	PMS1 PMS2 MSH6	3.16e-05	10	34	3	HP:0012118
HumanPheno	Shoulder contracture	HSPG2 COL12A1 JAG2	4.32e-05	11	34	3	HP:0034665
HumanPheno	Neuroblastoma	PMS1 HSPG2 PMS2 NSD1 MSH6	4.44e-05	61	34	5	HP:0003006
HumanPheno	Neuroblastic tumor	PMS1 HSPG2 PMS2 NSD1 MSH6	4.44e-05	61	34	5	HP:0004376
HumanPheno	Peripheral primitive neuroectodermal neoplasm	PMS1 HSPG2 PMS2 NSD1 MSH6	4.81e-05	62	34	5	HP:0030067
HumanPheno	Neoplasm of the oral cavity	PMS1 HSPG2 PMS2 KIAA0586 MSH6	4.81e-05	62	34	5	HP:0100649
HumanPheno	Primitive neuroectodermal tumor	PMS1 HSPG2 PMS2 NSD1 MSH6	7.01e-05	67	34	5	HP:0030065
HumanPheno	Tibial bowing	FLNB FN1 PDGFRB RTL1	1.41e-04	41	34	4	HP:0002982
HumanPheno	Neoplasm of the larynx	PMS1 PMS2 MSH6	1.73e-04	17	34	3	HP:0100605
HumanPheno	Cardiac diverticulum	PMS1 PMS2 MSH6	2.07e-04	18	34	3	HP:0100571
HumanPheno	Abnormal limb epiphysis morphology	HSPG2 FLNB FN1 KIAA0586 TG RTL1	2.55e-04	138	34	6	HP:0006505
HumanPheno	Malrotation of colon	FLNB TFAP2A	2.57e-04	4	34	2	HP:0004785
HumanPheno	Glioma	PMS1 PMS2 NSD1 MSH6	2.62e-04	48	34	4	HP:0009733
HumanPheno	Abnormal large intestine morphology	PMS1 FLNB PMS2 MYLK PDGFRB KIAA0586 NSD1 SI TFAP2A MSH6 DKK1 CPT1C	2.73e-04	594	34	12	HP:0002250
HumanPheno	Abnormality of intracranial pressure	PMS1 PMS2 KIAA0586 MSH6 DKK1	2.86e-04	90	34	5	HP:0012640
HumanPheno	Increased intracranial pressure	PMS1 PMS2 KIAA0586 MSH6 DKK1	2.86e-04	90	34	5	HP:0002516
HumanPheno	Abnormally folded helix	HSPG2 AGO2 FN1 KIAA0586 TFAP2A	2.86e-04	90	34	5	HP:0008544
HumanPheno	Neuroepithelial neoplasm	PMS1 HSPG2 PMS2 NSD1 MSH6	3.17e-04	92	34	5	HP:0030063
HumanPheno	Neuroectodermal neoplasm	PMS1 HSPG2 PMS2 NSD1 MSH6	3.50e-04	94	34	5	HP:0030061
HumanPheno	Nervous tissue neoplasm	PMS1 HSPG2 PMS2 NSD1 MSH6	3.50e-04	94	34	5	HP:0030060
HumanPheno	Abnormal lower limb epiphysis morphology	HSPG2 FN1 KIAA0586 TG RTL1	3.50e-04	94	34	5	HP:0006500
HumanPheno	Exudative retinal detachment	CFH IGFBP7	4.27e-04	5	34	2	HP:0012231
HumanPheno	Malignant neoplasm of the central nervous system	PMS1 HSPG2 PMS2 NSD1 MSH6	4.46e-04	99	34	5	HP:0100836
HumanPheno	Glioblastoma multiforme	PMS1 PMS2 MSH6	5.00e-04	24	34	3	HP:0012174
HumanPheno	Abnormal ossification involving the femoral head and neck	FLNB KIAA0586 TG	5.65e-04	25	34	3	HP:0009107
HumanPheno	Astrocytoma	PMS2 NSD1 MSH6	5.65e-04	25	34	3	HP:0009592
HumanPheno	Adenoma sebaceum	PMS1 PMS2 MSH6	5.65e-04	25	34	3	HP:0009720
HumanPheno	Long clavicles	FLNB KIAA0586 RTL1	5.65e-04	25	34	3	HP:0000890
HumanPheno	Enlarged cisterna magna	FLNB KIAA0586 NSD1 NEK8	6.20e-04	60	34	4	HP:0002280
HumanPheno	Abnormal salivary gland morphology	PMS1 PMS2 MSH6	6.36e-04	26	34	3	HP:0010286
HumanPheno	Endometrial carcinoma	PMS1 PMS2 MSH6	6.36e-04	26	34	3	HP:0012114
Domain	VWC_out	MUC5B JAG2 NELL1 FCGBP MUC6	5.84e-08	19	106	5	SM00215
Domain	IG	CNTN4 HSPG2 MYLK DSCAM PDGFRB OBSCN PTPRT IGSF10 NEO1 FCRL3 IGFBP7 FCRL5 BTNL9	7.68e-07	421	106	13	SM00409
Domain	Ig_sub	CNTN4 HSPG2 MYLK DSCAM PDGFRB OBSCN PTPRT IGSF10 NEO1 FCRL3 IGFBP7 FCRL5 BTNL9	7.68e-07	421	106	13	IPR003599
Domain	IGc2	CNTN4 HSPG2 MYLK DSCAM PDGFRB OBSCN IGSF10 NEO1 FCRL3 FCRL5	9.10e-07	235	106	10	SM00408
Domain	Ig_sub2	CNTN4 HSPG2 MYLK DSCAM PDGFRB OBSCN IGSF10 NEO1 FCRL3 FCRL5	9.10e-07	235	106	10	IPR003598
Domain	-	CNTN4 HSPG2 FLNB COL12A1 MYLK FN1 DSCAM PDGFRB OBSCN PTPRT IGSF10 NEO1 FCRL3 IGFBP7 FCRL5 BTNL9	1.00e-06	663	106	16	2.60.40.10
Domain	Ig_I-set	CNTN4 HSPG2 MYLK DSCAM PDGFRB OBSCN IGSF10 NEO1 IGFBP7	1.36e-06	190	106	9	IPR013098
Domain	I-set	CNTN4 HSPG2 MYLK DSCAM PDGFRB OBSCN IGSF10 NEO1 IGFBP7	1.36e-06	190	106	9	PF07679
Domain	Ig-like_fold	CNTN4 HSPG2 FLNB COL12A1 MYLK FN1 DSCAM PDGFRB OBSCN PTPRT IGSF10 NEO1 FCRL3 IGFBP7 FCRL5 BTNL9	2.27e-06	706	106	16	IPR013783
Domain	VWF_dom	MUC5B JAG2 NELL1 FCGBP MUC6	3.85e-06	42	106	5	IPR001007
Domain	fn3	CNTN4 COL12A1 MYLK FN1 DSCAM OBSCN PTPRT NEO1	3.95e-06	162	106	8	PF00041
Domain	IG_LIKE	CNTN4 HSPG2 MYLK DSCAM PDGFRB OBSCN PTPRT IGSF10 NEO1 FCRL3 IGFBP7 FCRL5 BTNL9	4.20e-06	491	106	13	PS50835
Domain	Ig-like_dom	CNTN4 HSPG2 MYLK DSCAM PDGFRB OBSCN PTPRT IGSF10 NEO1 FCRL3 IGFBP7 FCRL5 BTNL9	5.45e-06	503	106	13	IPR007110
Domain	FN3	CNTN4 COL12A1 MYLK FN1 DSCAM OBSCN PTPRT NEO1	1.05e-05	185	106	8	SM00060
Domain	FN3	CNTN4 COL12A1 MYLK FN1 DSCAM OBSCN PTPRT NEO1	1.78e-05	199	106	8	PS50853
Domain	FN3_dom	CNTN4 COL12A1 MYLK FN1 DSCAM OBSCN PTPRT NEO1	2.54e-05	209	106	8	IPR003961
Domain	Growth_fac_rcpt_	HSPG2 LAMB1 JAG2 CD93 NELL1 IGFBP5 IGFBP7	3.02e-05	156	106	7	IPR009030
Domain	C8	MUC5B FCGBP MUC6	3.77e-05	12	106	3	PF08742
Domain	TIL	MUC5B FCGBP MUC6	3.77e-05	12	106	3	PF01826
Domain	Unchr_dom_Cys-rich	MUC5B FCGBP MUC6	4.88e-05	13	106	3	IPR014853
Domain	C8	MUC5B FCGBP MUC6	4.88e-05	13	106	3	SM00832
Domain	TIL_dom	MUC5B FCGBP MUC6	6.18e-05	14	106	3	IPR002919
Domain	VWC	MUC5B JAG2 NELL1 FCGBP	6.24e-05	38	106	4	SM00214
Domain	IGv	HSPG2 DSCAM OBSCN IGSF10 BTNL9	6.74e-05	75	106	5	SM00406
Domain	VWF_type-D	MUC5B FCGBP MUC6	9.43e-05	16	106	3	IPR001846
Domain	VWFD	MUC5B FCGBP MUC6	9.43e-05	16	106	3	PS51233
Domain	VWD	MUC5B FCGBP MUC6	9.43e-05	16	106	3	SM00216
Domain	VWD	MUC5B FCGBP MUC6	9.43e-05	16	106	3	PF00094
Domain	ig	CNTN4 HSPG2 DSCAM PDGFRB OBSCN FCRL3 FCRL5	1.05e-04	190	106	7	PF00047
Domain	Immunoglobulin	CNTN4 HSPG2 DSCAM PDGFRB OBSCN FCRL3 FCRL5	1.05e-04	190	106	7	IPR013151
Domain	DNA_MISMATCH_REPAIR_1	PMS1 PMS2	1.90e-04	4	106	2	PS00058
Domain	DNA_mismatch_repair_C	PMS1 PMS2	1.90e-04	4	106	2	IPR013507
Domain	DNA_mismatch_repair_fam	PMS1 PMS2	1.90e-04	4	106	2	IPR002099
Domain	DNA_mis_repair	PMS1 PMS2	1.90e-04	4	106	2	PF01119
Domain	ConA-like_dom	HSPG2 COL12A1 FAT3 TRIM21 PTPRT NELL1 BTNL9	2.53e-04	219	106	7	IPR013320
Domain	SUSHI	CFH CSMD2 SEZ6L2 HPR	2.87e-04	56	106	4	PS50923
Domain	Sushi_SCR_CCP_dom	CFH CSMD2 SEZ6L2 HPR	3.07e-04	57	106	4	IPR000436
Domain	DNA_mismatch_repair_CS	PMS1 PMS2	3.16e-04	5	106	2	IPR014762
Domain	Laminin_G	HSPG2 COL12A1 FAT3 NELL1	3.29e-04	58	106	4	IPR001791
Domain	EGF	HSPG2 FAT3 LAMB1 JAG2 CD93 NELL1 FCGBP	3.87e-04	235	106	7	SM00181
Domain	EGF-like_dom	HSPG2 FAT3 LAMB1 JAG2 CD93 NELL1 FCGBP	5.47e-04	249	106	7	IPR000742
Domain	EGF_CA	HSPG2 FAT3 JAG2 CD93 NELL1	6.56e-04	122	106	5	SM00179
Domain	EGF-like_Ca-bd_dom	HSPG2 FAT3 JAG2 CD93 NELL1	7.06e-04	124	106	5	IPR001881
Domain	EGF-like_CS	HSPG2 FN1 FAT3 LAMB1 JAG2 CD93 NELL1	7.22e-04	261	106	7	IPR013032
Domain	Ig_2	HSPG2 NEO1 FCRL3 FCRL5	7.90e-04	73	106	4	PF13895
Domain	VWFC_1	MUC5B JAG2 NELL1	1.11e-03	36	106	3	PS01208
Domain	ASC	ASIC5 SCNN1D	1.12e-03	9	106	2	PF00858
Domain	ASC	ASIC5 SCNN1D	1.12e-03	9	106	2	PS01206
Domain	Na+channel_ASC	ASIC5 SCNN1D	1.12e-03	9	106	2	IPR001873
Domain	VWFC_2	MUC5B JAG2 NELL1	1.30e-03	38	106	3	PS50184
Domain	EGF_CA	FAT3 JAG2 CD93 NELL1	1.46e-03	86	106	4	PF07645
Domain	Laminin_G_2	HSPG2 FAT3 NELL1	1.51e-03	40	106	3	PF02210
Domain	LamG	HSPG2 FAT3 NELL1	1.99e-03	44	106	3	SM00282
Domain	-	HSPG2 COL12A1 FAT3 NELL1	2.10e-03	95	106	4	2.60.120.200
Domain	EGF_Ca-bd_CS	FAT3 JAG2 CD93 NELL1	2.27e-03	97	106	4	IPR018097
Domain	EGF_CA	FAT3 JAG2 CD93 NELL1	2.44e-03	99	106	4	PS01187
Domain	ASX_HYDROXYL	FAT3 JAG2 CD93 NELL1	2.53e-03	100	106	4	PS00010
Domain	FN_type2_col-bd	FN1 LY75	2.78e-03	14	106	2	IPR000562
Domain	FN2_2	FN1 LY75	2.78e-03	14	106	2	PS51092
Domain	FN2_1	FN1 LY75	2.78e-03	14	106	2	PS00023
Domain	fn2	FN1 LY75	2.78e-03	14	106	2	PF00040
Domain	FN2	FN1 LY75	2.78e-03	14	106	2	SM00059
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT3 JAG2 CD93 NELL1	3.13e-03	106	106	4	IPR000152
Domain	Sushi	CFH CSMD2 SEZ6L2	3.21e-03	52	106	3	PF00084
Domain	EGF_1	HSPG2 FN1 FAT3 LAMB1 JAG2 NELL1	3.34e-03	255	106	6	PS00022
Domain	CCP	CFH CSMD2 SEZ6L2	3.57e-03	54	106	3	SM00032
Domain	EGF_2	HSPG2 FAT3 LAMB1 JAG2 CD93 NELL1	4.03e-03	265	106	6	PS01186
Domain	-	TG IGFBP5	4.10e-03	17	106	2	4.10.800.10
Domain	Thyroglobulin_1	TG IGFBP5	4.10e-03	17	106	2	IPR000716
Domain	THYROGLOBULIN_1_1	TG IGFBP5	4.10e-03	17	106	2	PS00484
Domain	TY	TG IGFBP5	4.10e-03	17	106	2	SM00211
Domain	THYROGLOBULIN_1_2	TG IGFBP5	4.10e-03	17	106	2	PS51162
Domain	Thyroglobulin_1	TG IGFBP5	4.10e-03	17	106	2	PF00086
Domain	HATPase_c	PMS1 PMS2	4.60e-03	18	106	2	SM00387
Domain	IB	IGFBP5 IGFBP7	4.60e-03	18	106	2	SM00121
Domain	HATPase_c	PMS1 PMS2	5.12e-03	19	106	2	PF02518
Domain	Ig_V-set	HSPG2 DSCAM OBSCN IGSF10 BTNL9	5.55e-03	199	106	5	IPR013106
Domain	IGFBP	IGFBP5 IGFBP7	5.67e-03	20	106	2	PF00219
Domain	IGFBP-like	IGFBP5 IGFBP7	5.67e-03	20	106	2	IPR000867
Domain	IGFBP_N_2	IGFBP5 IGFBP7	5.67e-03	20	106	2	PS51323
Domain	PWWP	NSD1 MSH6	5.67e-03	20	106	2	SM00293
Pubmed	MUC5B mucin production is upregulated by fibronectin and laminin in human lung epithelial cells via the integrin and ERK dependent pathway.	FN1 LAMB1 MUC5B	3.08e-08	3	110	3	26057585
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FLNB FN1 MCPH1 HSPBAP1 OBSCN ICE1 REV3L CSMD2 ERLEC1 IGSF10 MSH6 FBXO43 LRRC7 DYNC1H1	9.03e-08	736	110	14	29676528
Pubmed	Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.	PMS1 PMS2 MSH6	1.23e-07	4	110	3	10480359
Pubmed	Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.	A2M HSPG2 COL12A1 FN1 HPR	2.84e-07	44	110	5	31273033
Pubmed	N-terminus of hMLH1 confers interaction of hMutLalpha and hMutLbeta with hMutSalpha.	PMS1 PMS2 MSH6	3.06e-07	5	110	3	12799449
Pubmed	Identification of mismatch repair protein complexes in HeLa nuclear extracts and their interaction with heteroduplex DNA.	PMS1 PMS2 MSH6	3.06e-07	5	110	3	10748159
Pubmed	Protein profile of exosomes from trabecular meshwork cells.	A2M HSPG2 COL12A1 LAMB1 DYNC1H1	4.93e-07	49	110	5	21362503
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 CFH CNTN4 FLNB PMS2 SORBS2 FN1 DSCAM PDGFRB LAMB1 REV3L NELL1 FAIM PDZD8 USP54 PJA1 DYNC1H1	6.05e-07	1285	110	17	35914814
Pubmed	hMutSalpha forms an ATP-dependent complex with hMutLalpha and hMutLbeta on DNA.	PMS1 PMS2 MSH6	6.11e-07	6	110	3	11809883
Pubmed	DNA mismatch repair and cancer.	PMS1 PMS2 MSH6	6.11e-07	6	110	3	11223406
Pubmed	Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer.	PMS1 PMS2 MSH6	1.07e-06	7	110	3	19115210
Pubmed	Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.	PMS1 PMS2 MSH6	1.07e-06	7	110	3	18723338
Pubmed	Common variants in mismatch repair genes and risk of invasive ovarian cancer.	PMS1 PMS2 MSH6	1.07e-06	7	110	3	16774946
Pubmed	Common variants in mismatch repair genes and risk of colorectal cancer.	PMS1 PMS2 MSH6	1.07e-06	7	110	3	18364438
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	A2M CFH CNTN4 HSPG2 FN1 LAMB1 NEO1 FCGBP	1.71e-06	257	110	8	16335952
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	HSPG2 FLNB LAMB1 TFAP2A MSH6 ANKRD17 DYNC1H1	3.98e-06	203	110	7	22083510
Pubmed	Ontogenesis of the tear drainage system requires Prickle1-driven polarized basement membrane deposition.	HSPG2 FN1 LAMB1	8.60e-06	13	110	3	33144400
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	A2M HSPG2 COL12A1 FN1 LAMB1 IGFBP7	9.65e-06	153	110	6	25037231
Pubmed	Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.	PMS2 MSH6	9.91e-06	2	110	2	28466842
Pubmed	Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes.	URI1 CCNE1	9.91e-06	2	110	2	25527175
Pubmed	MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.	PMS2 MSH6	9.91e-06	2	110	2	29345684
Pubmed	Germline mutation and protein expression analysis of mismatch repair genes MSH6 and PMS2 in Malaysian Lynch syndrome patients.	PMS2 MSH6	9.91e-06	2	110	2	24072394
Pubmed	RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.	PMS2 MSH6	9.91e-06	2	110	2	18030674
Pubmed	The 116G > A MSH6 and IVS1-1121C > T PMS2 Genes Polymorphisms Modulate the Risk of the Sporadic Colorectal Cancer Development in Polish Population.	PMS2 MSH6	9.91e-06	2	110	2	28451866
Pubmed	Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes Its ligand-dependent action on cell migration.	FN1 IGFBP5	9.91e-06	2	110	2	14645245
Pubmed	Differential deposition of basement membrane components during formation of the caudal neural tube in the mouse embryo.	HSPG2 FN1	9.91e-06	2	110	2	3665768
Pubmed	Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome.	PMS2 MSH6	9.91e-06	2	110	2	35346574
Pubmed	Associations Between Mutations in MSH6 and PMS2 and Risk of Surveillance-detected Colorectal Cancer.	PMS2 MSH6	9.91e-06	2	110	2	32240831
Pubmed	The E3 Ubiquitin Ligase TRIM21 Regulates Basal Levels of PDGFRβ.	PDGFRB TRIM21	9.91e-06	2	110	2	37175489
Pubmed	Structural insight into CD93 recognition by IGFBP7.	CD93 IGFBP7	9.91e-06	2	110	2	38218180
Pubmed	Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.	PMS2 MSH6	9.91e-06	2	110	2	10954713
Pubmed	Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.	PMS1 PMS2	9.91e-06	2	110	2	8072530
Pubmed	Genetic risk of FCRL3 and FCRL5 polymorphisms in children with asthma and allergic rhinitis in a Chinese Han population.	FCRL3 FCRL5	9.91e-06	2	110	2	30771554
Pubmed	Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.	PMS2 MSH6	9.91e-06	2	110	2	20632815
Pubmed	Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.	PMS2 MSH6	9.91e-06	2	110	2	17557300
Pubmed	Defective Angiogenesis and Intraretinal Bleeding in Mouse Models With Disrupted Inner Retinal Lamination.	DSCAM FAT3	9.91e-06	2	110	2	27046121
Pubmed	Platelet-derived growth factor receptor regulates salivary gland morphogenesis via fibroblast growth factor expression.	HSPG2 PDGFRB LAMB1	1.09e-05	14	110	3	18559345
Pubmed	Apical ectodermal ridge morphogenesis in limb development is controlled by Arid3b-mediated regulation of cell movements.	FN1 JAG2 DKK1	1.36e-05	15	110	3	21307092
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	CFH HSPG2 COL12A1 FN1 LAMB1 IGFBP7 HPR	1.47e-05	248	110	7	24006456
Pubmed	SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.	HSPG2 FLNB COL12A1 FN1 CD93 DYNC1H1	1.94e-05	173	110	6	23979707
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	HSPG2 COL12A1 FN1 LAMB1	1.95e-05	50	110	4	23658023
Pubmed	Identification PMS1 and PMS2 as potential meiotic substrates of CDK2 activity.	PMS1 PMS2	2.97e-05	3	110	2	36952545
Pubmed	Analysis of the MLH1, MLH2, MLH6, PMS2 genes and their correlations with clinical data in rectal mucinous adenocarcinoma.	PMS1 PMS2	2.97e-05	3	110	2	34807001
Pubmed	IGFBP-3 and IGFBP-5 associate with the cell binding domain (CBD) of fibronectin.	FN1 IGFBP5	2.97e-05	3	110	2	19236847
Pubmed	Nebulized Menthol Impairs Mucociliary Clearance via TRPM8 and MUC5AC/MUC5B in Primary Airway Epithelial Cells.	MUC5B TRPM8	2.97e-05	3	110	2	36675209
Pubmed	Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.	PMS2 MSH6	2.97e-05	3	110	2	27803051
Pubmed	Silencing of long noncoding RNA MYLK-AS1 suppresses nephroblastoma via down-regulation of CCNE1 through transcription factor TCF7L2.	MYLK CCNE1	2.97e-05	3	110	2	33438217
Pubmed	Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.	PMS1 PMS2	2.97e-05	3	110	2	9500552
Pubmed	Immunohistochemical localization of syndecan-1 in the dental follicle of postnatal mouse teeth.	HSPG2 FN1	2.97e-05	3	110	2	17608588
Pubmed	Immunohistochemical localization of extracellular matrix proteins in developing lung tissues.	FN1 LAMB1	2.97e-05	3	110	2	17334455
Pubmed	Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer.	URI1 CCNE1	2.97e-05	3	110	2	27582547
Pubmed	Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association.	HSPG2 FN1	2.97e-05	3	110	2	19553700
Pubmed	Multiple mutations and frameshifts are the hallmark of defective hPMS2 in pZ189-transfected human tumor cells.	PMS2 MSH6	2.97e-05	3	110	2	10871409
Pubmed	Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression.	TFAP2A IGFBP5	2.97e-05	3	110	2	7559606
Pubmed	Isolation and characterization of fibronectin-alpha 1-microglobulin complex in rat plasma.	A2M FN1	2.97e-05	3	110	2	7519849
Pubmed	Evaluation of JUN, FN1 and LAMB1 polymorphisms in pterygium in a Chinese Han population.	FN1 LAMB1	2.97e-05	3	110	2	35445627
Pubmed	Pms2 suppresses large expansions of the (GAA·TTC)n sequence in neuronal tissues.	PMS2 MSH6	2.97e-05	3	110	2	23071719
Pubmed	PDGFRβ-positive cell-mediated post-stroke remodeling of fibronectin and laminin α2 for tissue repair and functional recovery.	FN1 PDGFRB	2.97e-05	3	110	2	36514952
Pubmed	Initiation of fibronectin fibrillogenesis is an enzyme-dependent process.	FN1 TFAP2A	2.97e-05	3	110	2	37148241
Pubmed	Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer.	A2M FN1	2.97e-05	3	110	2	27498393
Pubmed	An mTurq2-Col4a1 mouse model allows for live visualization of mammalian basement membrane development.	HSPG2 LAMB1	2.97e-05	3	110	2	38051393
Pubmed	IGFBP6 regulates vascular smooth muscle cell proliferation and morphology via cyclin E-CDK2.	CCNE1 IGFBP7	2.97e-05	3	110	2	32529639
Pubmed	Prediction Model for Gastric Cancer With DNA Mismatch Repair Deficiency.	PMS2 MSH6	2.97e-05	3	110	2	33517304
Pubmed	Mesenchymal stromal cells: inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential.	FN1 PDGFRB	2.97e-05	3	110	2	24022915
Pubmed	Mask family proteins ANKHD1 and ANKRD17 regulate YAP nuclear import and stability.	ANKHD1 ANKRD17	2.97e-05	3	110	2	31661072
Pubmed	Immunohistochemical study of the extracellular matrix proteins laminin, fibronectin and type IV collagen in secretory meningiomas.	FN1 LAMB1	2.97e-05	3	110	2	18474427
Pubmed	Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia.	HSPG2 FN1 LAMB1 JAG2 NELL1	3.80e-05	118	110	5	21078624
Pubmed	Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.	PMS2 MSH6	5.92e-05	4	110	2	26097592
Pubmed	Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability.	PMS2 MSH6	5.92e-05	4	110	2	24643686
Pubmed	Prediction of Lynch syndrome in consecutive patients with colorectal cancer.	PMS2 MSH6	5.92e-05	4	110	2	19244167
Pubmed	Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.	PMS2 MSH6	5.92e-05	4	110	2	16116158
Pubmed	Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.	PMS2 MSH6	5.92e-05	4	110	2	21911971
Pubmed	Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes.	PMS2 MSH6	5.92e-05	4	110	2	21559014
Pubmed	A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays.	PMS2 MSH6	5.92e-05	4	110	2	24989436
Pubmed	The little elongation complex functions at initiation and elongation phases of snRNA gene transcription.	ICE1 ELL	5.92e-05	4	110	2	23932780
Pubmed	Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.	PMS2 MSH6	5.92e-05	4	110	2	36073783
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	MYLK OBSCN	5.92e-05	4	110	2	26147384
Pubmed	Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.	PMS2 MSH6	5.92e-05	4	110	2	19526325
Pubmed	Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?	PMS2 MSH6	5.92e-05	4	110	2	23434150
Pubmed	p53 represses the transcription of snRNA genes by preventing the formation of little elongation complex.	ICE1 ELL	5.92e-05	4	110	2	27268141
Pubmed	Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer.	PMS2 MSH6	5.92e-05	4	110	2	33574476
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC6	5.92e-05	4	110	2	23807779
Pubmed	PMS2 involvement in patients suspected of Lynch syndrome.	PMS2 MSH6	5.92e-05	4	110	2	19132747
Pubmed	Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.	PMS2 MSH6	5.92e-05	4	110	2	26544533
Pubmed	Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.	PMS2 MSH6	5.92e-05	4	110	2	27601186
Pubmed	Colorectal cancer in Iran: immunohistochemical profiles of four mismatch repair proteins.	PMS2 MSH6	5.92e-05	4	110	2	19707776
Pubmed	Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.	PMS2 MSH6	5.92e-05	4	110	2	16885385
Pubmed	Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.	PMS2 MSH6	5.92e-05	4	110	2	24323032
Pubmed	High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers.	PMS2 MSH6	5.92e-05	4	110	2	18841495
Pubmed	Analysis of the human MutLalpha.MutSalpha complex.	PMS2 MSH6	5.92e-05	4	110	2	16403449
Pubmed	Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.	PMS2 MSH6	5.92e-05	4	110	2	19898223
Pubmed	Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables.	PMS2 MSH6	5.92e-05	4	110	2	24444820
Pubmed	Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study.	PMS2 MSH6	5.92e-05	4	110	2	16740762
Pubmed	Gene fusion and overlapping reading frames in the mammalian genes for 4E-BP3 and MASK.	ANKHD1 ANKRD17	5.92e-05	4	110	2	14557257
Pubmed	DNA mismatch repair protein expression and microsatellite instability in primary mucosal melanomas of the head and neck.	PMS2 MSH6	5.92e-05	4	110	2	17493242
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC6	5.92e-05	4	110	2	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC6	5.92e-05	4	110	2	14984930
Pubmed	Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.	PMS2 MSH6	5.92e-05	4	110	2	17653898
Pubmed	The mismatch repair system protects against intergenerational GAA repeat instability in a Friedreich ataxia mouse model.	PMS2 MSH6	5.92e-05	4	110	2	22289650
Pubmed	An intact Pms2 ATPase domain is not essential for male fertility.	PMS1 PMS2	5.92e-05	4	110	2	26753533
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CNTN4 HSPG2 MYLK DSCAM PDGFRB OBSCN IGSF10 NEO1 IGFBP7	2.14e-08	161	75	9	593
GeneFamily	Fibronectin type III domain containing	CNTN4 COL12A1 MYLK FN1 DSCAM OBSCN PTPRT NEO1	3.22e-07	160	75	8	555
GeneFamily	Immunoglobulin like domain containing	CNTN4 HSPG2 DSCAM PDGFRB PTPRT NEO1 FCRL3 FCRL5	1.33e-06	193	75	8	594
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFH CSMD2 SEZ6L2 HPR	9.13e-05	57	75	4	1179
GeneFamily	MutL homologs	PMS1 PMS2	1.01e-04	4	75	2	1027
GeneFamily	CD molecules\|Mucins	MUC5B MUC6	3.39e-03	21	75	2	648
GeneFamily	PWWP domain containing	NSD1 MSH6	3.72e-03	22	75	2	1147
Coexpression	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	A2M CFH HSPG2 COL12A1 MYLK FN1 LAMB1 CD93 IGFBP5 IGFBP7	1.64e-08	211	107	10	M12225
Coexpression	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	AKAP6 FN1 CPA2 JAG2 NEO1 FCGBP DKK1 IGFBP5 IGFBP7 TLE2	2.77e-06	368	107	10	M16431
Coexpression	SABATES_COLORECTAL_ADENOMA_DN	CFH WSCD1 CNTN4 SORBS2 MYLK FN1 PNLIPRP2 SI FCRL3	3.91e-06	299	107	9	M14791
Coexpression	LU_EZH2_TARGETS_DN	AGO2 MYLK AAK1 LAMB1 CCNE1 ZBTB34 DKK1 C6orf120 ANKRD17 FAM83D	5.77e-06	400	107	10	M2140
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	A2M FLNB FN1 FAT3 SEZ6L2 DKK1 IGFBP5 IGFBP7 FRMD6	1.02e-05	337	107	9	M13206
Coexpression	NABA_CORE_MATRISOME	HSPG2 COL12A1 FN1 LAMB1 IGSF10 NELL1 IGFBP5 IGFBP7	1.55e-05	270	107	8	MM17057
Coexpression	NABA_CORE_MATRISOME	HSPG2 COL12A1 FN1 LAMB1 IGSF10 NELL1 IGFBP5 IGFBP7	1.76e-05	275	107	8	M5884
Coexpression	GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	PCED1A ARPP21 FAT3 SEZ6L2 NEO1 FBXO43 SLC15A5	1.80e-05	199	107	7	M8082
Coexpression	FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2	CFH MYLK FN1 PDGFRB LAMB1 OLFML2A IGFBP7 FRMD6	3.52e-05	303	107	8	M39040
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	A2M CFH COL12A1 PDGFRB OBSCN CD93 OLFML2A IGFBP5 IGFBP7 FRMD6	4.27e-05	505	107	10	M39167
Coexpression	JONES_OVARY_STROMAL	CFH COL12A1 MYLK PDGFRB IGFBP5 IGFBP7	4.45e-05	156	107	6	M48352
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL	HSPG2 LAMB1 TMEM71 OLFML2A IGFBP7	4.93e-05	97	107	5	M45794
Coexpression	JONES_OVARY_MACROPHAGE	A2M CFH MYLK PDGFRB CD93 IGFBP5 IGFBP7	6.41e-05	243	107	7	M48355
Coexpression	WAKASUGI_HAVE_ZNF143_BINDING_SITES	PMS1 PMS2 REV3L MSH6	7.09e-05	54	107	4	M9575
Coexpression	JONES_OVARY_PERICYTE	A2M COL12A1 MYLK PDGFRB IGFBP5 IGFBP7	7.65e-05	172	107	6	M48351
Coexpression	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	A2M COL12A1 ARPP21 CCDC7 LRRTM2 SLC15A5 RSPH10B	9.54e-05	259	107	7	M9331
Coexpression	NABA_ECM_GLYCOPROTEINS	FN1 LAMB1 IGSF10 NELL1 IGFBP5 IGFBP7	1.36e-04	191	107	6	MM17059
Coexpression	DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS	HSPG2 JAG2 CD93 BTNL9	1.47e-04	65	107	4	M40266
Coexpression	NABA_ECM_GLYCOPROTEINS	FN1 LAMB1 IGSF10 NELL1 IGFBP5 IGFBP7	1.56e-04	196	107	6	M3008
Coexpression	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	A2M PDGFRB IGFBP5	1.61e-04	26	107	3	M18077
Coexpression	BROWNE_HCMV_INFECTION_48HR_DN	CFH WSCD1 HSPG2 PMS2 FN1 LAMB1 OLFML2A IGFBP5 MUC6	1.63e-04	482	107	9	M12144
Coexpression	GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP	AGO2 TG JAG2 DKK1 C6orf120 PDZD8	1.65e-04	198	107	6	M9571
Coexpression	AIZARANI_LIVER_C33_STELLATE_CELLS_2	A2M MYLK LAMB1 IGFBP5 IGFBP7	1.70e-04	126	107	5	M39132
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN	PMS1 CNTN4 PMS2 TMEM71 CD93 FRMD6	1.75e-04	200	107	6	M8048
Coexpression	DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC	COL12A1 FN1 IGFBP7	1.80e-04	27	107	3	M47994
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	PMS1 AGO2 ICE1 REV3L CCNE1 ADSL DKK1	2.36e-04	300	107	7	M8702
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	CFH HSPG2 SORBS2 COL12A1 FN1 PDGFRB LAMB1 IGSF10 OLFML2A NEO1 IGFBP5 IGFBP7	3.37e-06	453	108	12	GSM777067_500
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	CFH HSPG2 PDGFRB LAMB1 IGSF10 IGFBP7	1.02e-05	97	108	6	GSM777043_100
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	CNTN4 SORBS2 COL12A1 FN1 PNLIPRP2 PDGFRB FAT3 PCDHB11 LAMB1 CPA2 IGSF10 NELL1 NEO1 IGFBP5 FRMD6	1.23e-05	797	108	15	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	CFH CNTN4 MYLK FN1 PDGFRB FAT3 PCDHB11 LAMB1 REV3L IGSF10 IGFBP5 IGFBP7 FAM83D PJA1	3.75e-05	773	108	14	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	CFH CNTN4 SORBS2 COL12A1 PNLIPRP2 PDGFRB FAT3 CPA2 REV3L IGSF10 NELL1 NEO1 IGFBP5 FRMD6	4.31e-05	783	108	14	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	CNTN4 FN1 PNLIPRP2 PDGFRB FAT3 PCDHB11 LAMB1 CPA2 REV3L IGSF10 DKK1 IGFBP5 IGFBP7 PJA1	4.95e-05	793	108	14	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	CFH MYLK PDGFRB FAT3 PCDHB11 LAMB1 IGSF10 IGFBP5 PJA1	5.53e-05	336	108	9	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	PDGFRB FAT3 PCDHB11 LAMB1 IGSF10 DKK1 IGFBP7	5.53e-05	191	108	7	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000
CoexpressionAtlas	kidney_adult_RenCorpuscGlomer_k-means-cluster#1_top-relative-expression-ranked_500	CFH SORBS2 PDGFRB IGFBP5 IGFBP7	5.84e-05	81	108	5	gudmap_kidney_adult_RenCorpuscGlomer_k1_500
CoexpressionAtlas	dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_500	COL12A1 FN1 FAT3 CD93	7.35e-05	44	108	4	gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k3_500
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_200	SORBS2 COL12A1 PDGFRB IGFBP7	7.35e-05	44	108	4	gudmap_kidney_P0_JuxtaGlom_Ren1_k3_200
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	CFH FN1 PDGFRB IGFBP5 IGFBP7	7.36e-05	85	108	5	GSM777067_100
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500	CFH CNTN4 SORBS2 COL12A1 PDGFRB CPA2 IGSF10 NELL1 IGFBP5	8.80e-05	357	108	9	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000	CNTN4 COL12A1 FN1 PDGFRB FAT3 PTPRT CCNE1 IGSF10 CD93 NELL1 IGFBP7 RTL1 LRRC7	9.08e-05	734	108	13	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	CFH CNTN4 SORBS2 COL12A1 PDGFRB FAT3 CPA2 REV3L IGSF10 NELL1 NEO1 IGFBP5 FRMD6	9.85e-05	740	108	13	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	CFH HSPG2 COL12A1 FN1 LAMB1 CD93 OLFML2A IGFBP5 IGFBP7 BTNL9	1.01e-04	450	108	10	GSM777063_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	CFH CNTN4 PNLIPRP2 PDGFRB FAT3 LAMB1 REV3L ATP8B2 IGSF10 IGFBP5 IGFBP7 FAM83D PJA1	1.42e-04	768	108	13	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_1000	CNTN4 SORBS2 COL12A1 PNLIPRP2 CPA2 REV3L NEO1 FRMD6	1.53e-04	301	108	8	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_1000
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100	CNTN4 COL12A1 CPA2	1.59e-04	21	108	3	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_100
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	CFH MYLK FN1 PDGFRB FAT3 PCDHB11 LAMB1 REV3L IGSF10 DKK1 IGFBP5 IGFBP7 PJA1	1.60e-04	777	108	13	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_200	CNTN4 COL12A1 CPA2 FRMD6	1.77e-04	55	108	4	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_200
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	FN1 PDGFRB FAT3 PCDHB11 LAMB1 IGSF10	2.20e-04	168	108	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500	CNTN4 SORBS2 COL12A1 PNLIPRP2 CPA2 TRIM21 REV3L NEO1 FRMD6	2.66e-04	414	108	9	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_200	SORBS2 COL12A1 FN1 PDGFRB CD93 IGFBP7	2.92e-04	177	108	6	gudmap_kidney_P0_JuxtaGlom_Ren1_200
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000	CNTN4 SORBS2 COL12A1 PNLIPRP2 CPA2 NEO1 FRMD6	3.00e-04	251	108	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	CFH HSPG2 COL12A1 FN1 LAMB1 CD93 IGFBP5 IGFBP7 BTNL9	4.09e-04	439	108	9	GSM777059_500
CoexpressionAtlas	kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000	PMS2 SORBS2 AGO2 MYLK FAT3 PCDHB11 LAMB1 WDR54 TFAP2A NELL1 IGFBP5 LY75	4.28e-04	749	108	12	gudmap_kidney_P3_CapMes_Crym_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_100	CNTN4 SORBS2 COL12A1 CPA2	4.99e-04	72	108	4	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4	CNTN4 ARPP21 PDGFRB CPA2 REV3L IGSF10 CD93 NELL1 FRMD6 SLC15A5 MUC6	5.08e-04	655	108	11	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	FN1 PDGFRB FAT3 PCDHB11 IGSF10 DKK1 IGFBP5 IGFBP7	5.19e-04	361	108	8	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4	CFH HSPG2 FN1 PDGFRB LAMB1 IGSF10 NEO1 IGFBP5 IGFBP7	5.29e-04	455	108	9	GSM777055_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_500	CNTN4 SORBS2 COL12A1 CPA2	5.83e-04	75	108	4	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_500
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000	CNTN4 SORBS2 COL12A1 CPA2 TRIM21 FRMD6 LY75	5.89e-04	281	108	7	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_1000
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_500	SORBS2 PDGFRB IGFBP5 IGFBP7	6.13e-04	76	108	4	gudmap_kidney_P0_JuxtaGlom_Ren1_k3_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4	CNTN4 ARPP21 IGSF10 IGFBP7 PRICKLE3 MUC6	6.20e-04	204	108	6	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K4
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	CFH HSPG2 FN1 PDGFRB LAMB1 IGSF10 NEO1 IGFBP5 IGFBP7	6.27e-04	466	108	9	GSM777050_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500	CNTN4 SORBS2 COL12A1 PNLIPRP2 PDGFRB CPA2 IGSF10 IGFBP5	6.32e-04	372	108	8	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500
CoexpressionAtlas	JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3	COL12A1 MYLK FN1 PDGFRB IGFBP5 FRMD6	6.53e-04	206	108	6	JC_fibro_500_K3
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100	CNTN4 SORBS2 COL12A1 CPA2	6.76e-04	78	108	4	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_100
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200	CNTN4 SORBS2 COL12A1 CPA2 IGFBP5	6.80e-04	137	108	5	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_100	CNTN4 COL12A1 CPA2	6.83e-04	34	108	3	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_100
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000	CFH SORBS2 COL12A1 AGO2 MYLK FN1 PDGFRB FAT3 CD93 IGFBP5 IGFBP7 LRRC7 TMEM252	6.85e-04	905	108	13	gudmap_kidney_P0_JuxtaGlom_Ren1_1000
CoexpressionAtlas	kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_200	CFH COL12A1	7.03e-04	8	108	2	gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_200
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200	CNTN4 COL12A1 PNLIPRP2 PDGFRB CPA2	8.26e-04	143	108	5	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100	CNTN4 COL12A1 PNLIPRP2 CPA2	8.93e-04	84	108	4	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_100
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_100	CNTN4 COL12A1 PNLIPRP2 CPA2	9.34e-04	85	108	4	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_100
CoexpressionAtlas	JC_fibro_top-relative-expression-ranked_500	AKAP6 COL12A1 MYLK FN1 PDGFRB TFAP2A DKK1 IGFBP5 FRMD6	9.48e-04	494	108	9	JC_fibro_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_100	MYLK FAT3 REV3L TFAP2A	9.76e-04	86	108	4	gudmap_developingLowerUrinaryTract_e14.5_ urethra_100
CoexpressionAtlas	Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4	FN1 PDGFRB IGFBP5 IGFBP7	9.76e-04	86	108	4	GSM777055_100
CoexpressionAtlas	MESO-5 blastocyst_vs_MESO-5 bone marrow-Confounder_removed-fold2.0_adjp0.05	HSPG2 FN1 IGFBP5 CPT1C	9.76e-04	86	108	4	PCBC_ratio_MESO-5 blastocyst_vs_MESO-5 bone marrow_cfr-2X-p05
CoexpressionAtlas	ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500	AKAP6 A2M COL12A1 FN1 TFAP2A NELL1 DKK1 IGFBP5 IGFBP7	1.00e-03	498	108	9	PCBC_ratio_EB_vs_SC_500
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	A2M HSPG2 COL12A1 FN1 LAMB1 TFAP2A OLFML2A IGFBP5 IGFBP7 FRMD6	5.40e-11	193	110	10	e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	A2M HSPG2 COL12A1 FN1 LAMB1 TFAP2A OLFML2A IGFBP5 IGFBP7 FRMD6	5.40e-11	193	110	10	b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCell	ASK452-Mesenchymal-Fibroblast\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	A2M CFH MYLK FN1 PDGFRB LAMB1 DKK1 IGFBP5 IGFBP7 FRMD6	7.29e-11	199	110	10	4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6
ToppCell	ILEUM-non-inflamed-(8)_Fibroblasts\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M CFH FLNB COL12A1 MYLK FN1 PDGFRB LAMB1 IGFBP5 IGFBP7	7.29e-11	199	110	10	d9d7f36b4b5592b7855448730044c90997b55499
ToppCell	ASK452-Mesenchymal\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	A2M CFH MYLK FN1 PDGFRB LAMB1 DKK1 IGFBP5 IGFBP7 FRMD6	7.29e-11	199	110	10	93e85e3731a9ece9aee3eb82c5dfdad331ee62d6
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M CFH FLNB COL12A1 MYLK FN1 PDGFRB LAMB1 IGFBP5 IGFBP7	7.29e-11	199	110	10	6a0df9a2f30480043f9c1d7fbdede17eb0910cac
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	AKAP6 A2M CNTN4 FLNB MYLK FN1 PDGFRB FAT3 IGFBP7	8.16e-10	183	110	9	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M HSPG2 COL12A1 FN1 PDGFRB FAT3 OLFML2A IGFBP5 FRMD6	1.03e-09	188	110	9	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	5'-Adult-Appendix-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 A2M SORBS2 MYLK PDGFRB OLFML2A IGFBP5 IGFBP7 HPR	1.08e-09	189	110	9	0daa8efac08dca9525d2b8d421952068cab4eb50
ToppCell	5'-Adult-Appendix-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 A2M SORBS2 MYLK PDGFRB OLFML2A IGFBP5 IGFBP7 HPR	1.08e-09	189	110	9	b6bb4327b4560d07d2b728abcc5f144f428948a5
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH COL12A1 MYLK FN1 PDGFRB LAMB1 CSMD2 IGFBP5 FRMD6	1.25e-09	192	110	9	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	368C-Fibroblasts-Fibroblast-G\|368C / Donor, Lineage, Cell class and subclass (all cells)	A2M CFH MYLK FN1 FAT3 LAMB1 IGSF10 OLFML2A IGFBP5	1.56e-09	197	110	9	156155c2f0c1a2461e45803da578af18ee221660
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	A2M CFH COL12A1 MYLK FN1 PDGFRB LAMB1 CSMD2 FRMD6	1.56e-09	197	110	9	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	368C-Fibroblasts-Fibroblast-G-\|368C / Donor, Lineage, Cell class and subclass (all cells)	A2M CFH MYLK FN1 FAT3 LAMB1 IGSF10 OLFML2A IGFBP5	1.56e-09	197	110	9	d5d9263451f6c10cb3b9c17740183ca334e24851
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 A2M SORBS2 MYLK PDGFRB OLFML2A IGFBP5 IGFBP7 HPR	1.56e-09	197	110	9	d16bb765afdc02406ffd7ce6a75bae72b66db66c
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	A2M CFH MYLK FN1 PDGFRB LAMB1 CSMD2 IGFBP7 FRMD6	1.56e-09	197	110	9	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 A2M SORBS2 MYLK PDGFRB OLFML2A IGFBP5 IGFBP7 HPR	1.56e-09	197	110	9	68c23c23b6924892f4c238cf2f5abc7927e04fbc
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	A2M CFH MYLK FN1 LAMB1 IGSF10 OLFML2A NELL1 IGFBP5	1.71e-09	199	110	9	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M CFH FLNB COL12A1 MYLK FN1 LAMB1 IGFBP5 IGFBP7	1.71e-09	199	110	9	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	ILEUM-inflamed-(8)_Fibroblast\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M CFH COL12A1 MYLK FN1 PDGFRB LAMB1 IGFBP5 IGFBP7	1.71e-09	199	110	9	cb3c04b91c8e8080137823b11c76ca0a2adda52d
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	A2M CFH MYLK FN1 PDGFRB LAMB1 IGSF10 OLFML2A IGFBP5	1.71e-09	199	110	9	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	A2M CFH MYLK FN1 PDGFRB LAMB1 IGSF10 OLFML2A IGFBP5	1.71e-09	199	110	9	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M CFH COL12A1 MYLK FN1 PDGFRB LAMB1 IGFBP5 IGFBP7	1.71e-09	199	110	9	a843bdfcb58bec5e2a94a5ec9d5b8c5e4aef15d2
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFH COL12A1 MYLK FN1 PDGFRB LAMB1 SEZ6L2 IGFBP5 FRMD6	1.78e-09	200	110	9	e663995fc44c340d878d66b278b7b5c2ff784301
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CNTN4 MYLK FN1 PDGFRB LAMB1 REV3L IGSF10 NELL1 IGFBP7	1.78e-09	200	110	9	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	5'-Adult-SmallIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M CFH COL12A1 FN1 PDGFRB LAMB1 IGSF10 IGFBP5 IGFBP7	1.78e-09	200	110	9	a637281d91e95734ee4f8510b3780e0272b16fda
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFH COL12A1 MYLK FN1 PDGFRB LAMB1 SEZ6L2 IGFBP5 FRMD6	1.78e-09	200	110	9	2cb8a39a12522a9643c6244d5e94cb4559868bb9
ToppCell	Lung_Parenchyma-Severe-Mesenchymal\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFH COL12A1 MYLK FN1 PDGFRB LAMB1 SEZ6L2 IGFBP7 FRMD6	1.78e-09	200	110	9	6ce8e2cf689523993d909a27daec3d6a5824d13c
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFH COL12A1 MYLK FN1 PDGFRB LAMB1 SEZ6L2 IGFBP7 FRMD6	1.78e-09	200	110	9	907427e85cebe5a18c8a310e2ffa0e180ea3cb77
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	CFH COL12A1 MYLK FN1 PDGFRB LAMB1 SEZ6L2 IGFBP5 FRMD6	1.78e-09	200	110	9	8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M CFH MYLK FN1 PCDHB11 LAMB1 IGFBP5 IGFBP7 HPR	1.78e-09	200	110	9	07641f476cb1a131c2a50258b88cc13bb38c8379
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	A2M CFH MYLK FN1 PCDHB11 LAMB1 IGFBP5 IGFBP7 HPR	1.78e-09	200	110	9	343fa6ba1f52d816d2e41466f674ff8360aecd81
ToppCell	Parenchyma_COVID-19-Stromal-TX\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	CFH COL12A1 MYLK FN1 PDGFRB LAMB1 SEZ6L2 IGFBP7 FRMD6	1.78e-09	200	110	9	8472baa74c48b67c5f08223025885c833458290b
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M CFH MYLK FN1 PCDHB11 LAMB1 IGFBP5 IGFBP7 HPR	1.78e-09	200	110	9	d0c00cdd52c2e001aec9b935f4e981ba77d0386a
ToppCell	normal_Lung-Fibroblasts-Pericytes\|normal_Lung / Location, Cell class and cell subclass	A2M CNTN4 COL12A1 PDGFRB OBSCN LAMB1 CPA2 IGFBP7	1.70e-08	181	110	8	f74941e49950027360d71ea3b205fc20c6929766
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	AKAP6 A2M CNTN4 FLNB MYLK FN1 PDGFRB FAT3	1.85e-08	183	110	8	818fd886e0188091310825f9145fa53328f2c979
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|tumor_Lung / Location, Cell class and cell subclass	A2M CNTN4 COL12A1 MYLK PDGFRB LAMB1 OLFML2A IGFBP7	1.85e-08	183	110	8	a03dd563af9b15cb1f5de5732a229405a9f82d84
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M CFH OBSCN LAMB1 REV3L CSMD2 IGFBP5 FRMD6	2.28e-08	188	110	8	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	AKAP6 A2M CNTN4 FLNB MYLK FN1 FAT3 FAM83D	2.38e-08	189	110	8	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	A2M CFH MYLK FN1 FAT3 LAMB1 IGFBP7 FRMD6	2.47e-08	190	110	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB FAT3 IGFBP5 FRMD6	2.58e-08	191	110	8	cc9a6a8fad17d6e1a08a68ab7512ae06b1249051
ToppCell	metastatic_Lymph_Node-Fibroblasts-Myofibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	HSPG2 COL12A1 MYLK PDGFRB LAMB1 IGFBP5 IGFBP7 FRMD6	2.58e-08	191	110	8	aa43b472bc8362f79ae63f09f1ca764718bbf22c
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB FAT3 IGFBP5 FRMD6	2.58e-08	191	110	8	c16b920ee69ea8536e020ac3475abf1ce972c1e6
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNTN4 MYLK FN1 PDGFRB FAT3 LAMB1 IGSF10 NELL1	2.68e-08	192	110	8	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M MYLK FN1 LAMB1 NELL1 IGFBP5 IGFBP7 LRRTM2	2.79e-08	193	110	8	146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a
ToppCell	ILEUM-inflamed-(8)_Smooth_muscle_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M COL12A1 MYLK FN1 LAMB1 PTPRT IGFBP5 IGFBP7	2.79e-08	193	110	8	084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH COL12A1 MYLK FN1 PDGFRB IGFBP5 IGFBP7 FRMD6	2.79e-08	193	110	8	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	CFH MYLK FN1 PDGFRB LAMB1 CSMD2 IGFBP7 FRMD6	2.91e-08	194	110	8	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CFH COL12A1 MYLK FN1 PDGFRB LAMB1 OLFML2A IGFBP7	2.91e-08	194	110	8	78dcb9d48259afabe73b41c5508a73a8d62339a4
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNTN4 MYLK FN1 PDGFRB FAT3 LAMB1 IGSF10 NELL1	2.91e-08	194	110	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CFH COL12A1 MYLK FN1 PDGFRB LAMB1 OLFML2A IGFBP7	3.03e-08	195	110	8	d760d1423f9a8a373fe7b250ea9b1d67a0c0059f
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 A2M SORBS2 MYLK PDGFRB OLFML2A IGFBP5 IGFBP7	3.15e-08	196	110	8	ce6f7ddb8104471dc90347f427486379914d63b4
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M CFH HSPG2 FN1 JAG2 CD93 CPT1C BTNL9	3.15e-08	196	110	8	a20a56d8997d6db2a10046c8801c619a379de83c
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M CFH MYLK FN1 PDGFRB FAT3 LAMB1 IGSF10	3.15e-08	196	110	8	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 A2M SORBS2 MYLK PDGFRB OLFML2A IGFBP5 IGFBP7	3.15e-08	196	110	8	6d7179decea512dd49bb2d5f6a4f5989349d52a9
ToppCell	metastatic_Lymph_Node-Fibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	HSPG2 COL12A1 MYLK PDGFRB LAMB1 IGFBP5 IGFBP7 FRMD6	3.15e-08	196	110	8	275e153347caf94edc0c50021bbab49c8696fecb
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 CNTN4 MYLK FN1 PDGFRB FAT3 IGFBP5 IGFBP7	3.28e-08	197	110	8	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB LAMB1 OLFML2A FRMD6	3.28e-08	197	110	8	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	tumor_Lung-Fibroblasts-Myofibroblasts\|tumor_Lung / Location, Cell class and cell subclass	COL12A1 MYLK FN1 PDGFRB LAMB1 IGFBP5 IGFBP7 FRMD6	3.41e-08	198	110	8	31f9181dab689aabe9c6182c2ef7de65ba3f0ff6
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB FAT3 IGFBP5 FRMD6	3.41e-08	198	110	8	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	ILEUM-inflamed-(7)_CD36+_endothelial_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M HSPG2 SORBS2 JAG2 CD93 NELL1 IGFBP7 BTNL9	3.41e-08	198	110	8	05d6558c7990ad2277db999025a073d29b273dfc
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB FAT3 IGFBP5 FRMD6	3.41e-08	198	110	8	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	Parenchyma_COVID-19\|World / Sample group, Lineage and Cell type	A2M CFH COL12A1 PDGFRB LAMB1 SEZ6L2 FRMD6 FCRL5	3.41e-08	198	110	8	45ab554e6d0399b3182f089a25b2adf96de1144b
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CNTN4 SORBS2 COL12A1 MYLK FN1 PDGFRB IGFBP5 IGFBP7	3.54e-08	199	110	8	9a08c25bb4851ad4ac9db8916422280f71378c2c
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB FAT3 IGFBP5 FRMD6	3.54e-08	199	110	8	7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M CFH FN1 PDGFRB LAMB1 IGSF10 IGFBP5 IGFBP7	3.54e-08	199	110	8	0019cfaa586a450c2e4952d1184a540561c8d0ba
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB FAT3 IGFBP5 FRMD6	3.54e-08	199	110	8	f2ad641f36c577ff7019e88ad6b73ed7e46d8c74
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	A2M CFH HSPG2 FLNB FN1 LAMB1 JAG2 CD93	3.54e-08	199	110	8	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M CFH COL12A1 MYLK FN1 PDGFRB IGFBP5 IGFBP7	3.54e-08	199	110	8	50abd20eb461927fde0ec5caae501d7f2277cf78
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 A2M MYLK FN1 PDGFRB IGFBP5 IGFBP7 FAM83D	3.54e-08	199	110	8	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CNTN4 SORBS2 COL12A1 MYLK FN1 PDGFRB IGFBP5 IGFBP7	3.54e-08	199	110	8	2ed10c5e15c9d5ed0a8bea580842348d5698a07b
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M CFH MYLK FN1 PDGFRB LAMB1 IGSF10 FRMD6	3.68e-08	200	110	8	c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB FAT3 IGFBP5 FRMD6	3.68e-08	200	110	8	780d47f8eff630020dfae32218de495a7e9dbad6
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M CFH MYLK FN1 PDGFRB FAT3 LAMB1 IGFBP7	3.68e-08	200	110	8	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB FAT3 IGFBP5 FRMD6	3.68e-08	200	110	8	28dd127787a57276253548d1f030814b1af64481
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M CFH COL12A1 FN1 PDGFRB LAMB1 OLFML2A FRMD6	3.68e-08	200	110	8	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH CNTN4 COL12A1 FN1 PDGFRB LAMB1 IGSF10 IGFBP5	3.68e-08	200	110	8	6f7f015b5fa1f52374f2c7d9ba339012395eda5f
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	A2M CFH MYLK PDGFRB FAT3 LAMB1 IGSF10 IGFBP7	3.68e-08	200	110	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M CFH MYLK FN1 PDGFRB LAMB1 IGSF10 FRMD6	3.68e-08	200	110	8	137f8f9d255c66336d4f8b44b2e3f3de721f2bf0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M CFH MYLK PDGFRB FAT3 LAMB1 IGSF10 IGFBP7	3.68e-08	200	110	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	Parenchymal-10x3prime_v2-Stromal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	A2M CFH MYLK FN1 PDGFRB LAMB1 IGFBP5 IGFBP7	3.68e-08	200	110	8	f6be0f24e607abb9007823a54fb0b24d04990a89
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M HSPG2 FN1 JAG2 CD93 OLFML2A IGFBP5 BTNL9	3.68e-08	200	110	8	2e47888e041ec3d265425d1df97b6665c6da889c
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH COL12A1 FN1 PDGFRB LAMB1 IGSF10 IGFBP5 IGFBP7	3.68e-08	200	110	8	3a164e3971bcd62b148b813171c103adb81f972e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M CFH MYLK FN1 PDGFRB FAT3 LAMB1 IGFBP7	3.68e-08	200	110	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	A2M CFH COL12A1 MYLK FN1 PDGFRB LAMB1 IGFBP5	3.68e-08	200	110	8	251fd2923f108cd2086961d897244b392c32ad54
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M CFH COL12A1 MYLK FN1 PDGFRB IGFBP5 IGFBP7	3.68e-08	200	110	8	0655328373d1b58828e141ddb0dcbb2cce10dc50
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	A2M CFH MYLK FN1 PDGFRB LAMB1 IGSF10 FRMD6	3.68e-08	200	110	8	25d3865aa2ced11a5ed40013e83b47d942fdf582
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFH PDGFRB MUC5B CSMD2 IGFBP5 IGFBP7 LRRTM2 USP54	3.68e-08	200	110	8	29054cf55e88e1ac81a562d8dd9af9b7c749321d
ToppCell	5'-Adult-LargeIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M CFH COL12A1 FN1 PDGFRB LAMB1 IGFBP5 IGFBP7	3.68e-08	200	110	8	5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M CFH MYLK PDGFRB FAT3 LAMB1 IGSF10 IGFBP7	3.68e-08	200	110	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTN4 COL12A1 FAT3 MUC5B PTPRT CCDC7 TRPM8	1.48e-07	160	110	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTN4 COL12A1 FAT3 MUC5B PTPRT CCDC7 TRPM8	1.48e-07	160	110	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 FN1 PDGFRB NEO1 PJA1 ZNF543	1.82e-07	165	110	7	e2aebb2fe197151e019371b8960f76f0c2386f08
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 FN1 PDGFRB NEO1 PJA1 ZNF543	1.82e-07	165	110	7	b087771499aeb31cc4a338d2d0a9392a4ec1ac45
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 FN1 PDGFRB NEO1 PJA1 ZNF543	1.82e-07	165	110	7	d8f8b088fd28a6b9dbd6b51bcaee42000e963321
ToppCell	facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERLEC1 OLFML2A MSH6 TLE2 FAM83D PRMT9 BTNL9	1.97e-07	167	110	7	961e722442d786ab15d1e490941d2be265a9057a
ToppCell	facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERLEC1 OLFML2A MSH6 TLE2 FAM83D PRMT9 BTNL9	1.97e-07	167	110	7	3760efc35d4e7e9c2da1a20f9795ddea397e2206
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH COL12A1 MYLK PDGFRB LAMB1 IGFBP5 HPR	2.71e-07	175	110	7	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	A2M CFH FN1 PDGFRB LAMB1 IGFBP7 FRMD6	2.82e-07	176	110	7	2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	A2M CFH FN1 PDGFRB LAMB1 IGFBP7 FRMD6	2.82e-07	176	110	7	f33ab41d121b59d871ad7d48ca021524a027d2ef
Computational	Genes upregulated in subsets of cells of a given type within various tumors	A2M HSPG2 CD93 IGFBP7 BTNL9	1.19e-05	50	65	5	GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3
Computational	Genes upregulated in subsets of cells of a given type within various tumors	A2M FN1 IGFBP5 IGFBP7	2.28e-04	50	65	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	A2M MYLK PDGFRB IGFBP7	2.28e-04	50	65	4	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE
Disease	Malignant neoplasm of breast	AKAP6 FLNB FN1 OBSCN TFAP2A CCNE1 JAG2 MSH6 FCRL3 DKK1 IGFBP5 IGFBP7 PRICKLE3 LRRC7 FCRL5 USP54	8.53e-07	1074	102	16	C0006142
Disease	Neoplasm of uncertain or unknown behavior of ovary	PMS1 PMS2 CCNE1 MSH6	2.99e-06	29	102	4	C0496920
Disease	Ovarian Carcinoma	PMS1 PMS2 CCNE1 MSH6	3.44e-06	30	102	4	C0029925
Disease	growth/differentiation factor 8 measurement	PMS1 CFH	1.18e-05	2	102	2	EFO_0021960
Disease	cortical thickness	AKAP6 A2M HSPG2 FLNB COL12A1 MCPH1 FAT3 PCDHB11 TG JAG2 NELL1 ZBTB34 NEO1 ELL	2.94e-05	1113	102	14	EFO_0004840
Disease	Malignant neoplasm of endometrium	PMS1 PMS2 MSH6	3.15e-05	18	102	3	C0007103
Disease	Carcinoma in situ of endometrium	PMS1 PMS2 MSH6	3.15e-05	18	102	3	C0346191
Disease	Autoimmune thyroiditis	TG FCRL3	7.07e-05	4	102	2	C0920350
Disease	Constitutional Mismatch Repair Deficiency Syndrome	PMS2 MSH6	7.07e-05	4	102	2	C4321324
Disease	diablo homolog, mitochondrial measurement	CFH IGFBP7	7.07e-05	4	102	2	EFO_0020323
Disease	Turcot syndrome	PMS2 MSH6	7.07e-05	4	102	2	cv:C0265325
Disease	Lynch syndrome	PMS2 MSH6	7.07e-05	4	102	2	cv:C4552100
Disease	Lynch syndrome (is_implicated_in)	PMS1 PMS2 MSH6	7.70e-05	24	102	3	DOID:3883 (is_implicated_in)
Disease	response to venlafaxine	COL12A1 MCPH1 CSMD2	8.73e-05	25	102	3	EFO_0006328
Disease	ovarian neoplasm	PMS1 PMS2 URI1 CCNE1 MSH6	1.05e-04	134	102	5	C0919267
Disease	Hereditary non-polyposis colorectal cancer syndrome	PMS1 PMS2 MSH6	1.10e-04	27	102	3	C1112155
Disease	Malignant neoplasm of ovary	PMS1 PMS2 URI1 CCNE1 MSH6	1.16e-04	137	102	5	C1140680
Disease	hepatocellular adenoma (biomarker_via_orthology)	A2M HPR	1.18e-04	5	102	2	DOID:0050868 (biomarker_via_orthology)
Disease	Turcot syndrome (disorder)	PMS2 MSH6	1.18e-04	5	102	2	C0265325
Disease	Hereditary Nonpolyposis Colorectal Cancer	PMS1 PMS2 MSH6	1.37e-04	29	102	3	C1333990
Disease	Breast Cancer, Familial	PMS2 MCPH1 MSH6	1.52e-04	30	102	3	C0346153
Disease	Craniofacial Abnormalities	CNTN4 HSPG2 KIAA0586 TFAP2A JAG2	2.14e-04	156	102	5	C0376634
Disease	complement factor H-related protein 3 measurement	AKAP6 CFH COL12A1 AAK1 PTPRT	3.09e-04	169	102	5	EFO_0600056
Disease	microcephaly (is_implicated_in)	MCPH1 NSD1	3.27e-04	8	102	2	DOID:10907 (is_implicated_in)
Disease	Syndactyly	TFAP2A JAG2	3.27e-04	8	102	2	C0039075
Disease	Lynch Syndrome	PMS2 MSH6	4.19e-04	9	102	2	C4552100
Disease	Hepatocellular Adenoma	A2M NR1I3	4.19e-04	9	102	2	C0206669
Disease	serum metabolite measurement	CNTN4 SORBS2 MCPH1 LAMB1 REV3L TFAP2A TESPA1 PTPRT CCNE1 TRPM8 FCRL5	4.30e-04	945	102	11	EFO_0005653
Disease	Colorectal Carcinoma	AKAP6 CNTN4 PMS2 FN1 OBSCN PTPRT CD93 NELL1 MSH6	7.43e-04	702	102	9	C0009402
Disease	mismatch repair cancer syndrome (is_implicated_in)	PMS2 MSH6	7.64e-04	12	102	2	DOID:0112182 (is_implicated_in)
Disease	ferritin measurement	PMS1 FN1 TFAP2A ELL	7.88e-04	119	102	4	EFO_0004459
Disease	membranous glomerulonephritis (biomarker_via_orthology)	A2M CFH	1.05e-03	14	102	2	DOID:10976 (biomarker_via_orthology)
Disease	hypertension (biomarker_via_orthology)	HSPG2 FN1 PDGFRB CCNE1 HPR	1.17e-03	227	102	5	DOID:10763 (biomarker_via_orthology)
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 FLNB	1.95e-03	19	102	2	DOID:2256 (is_implicated_in)
Disease	anorectal malformation	MUC5B CSMD2	1.95e-03	19	102	2	MONDO_0019938
Disease	Endometrial Carcinoma	PMS1 PMS2 MSH6	2.01e-03	72	102	3	C0476089
Disease	Autistic Disorder	CNTN4 NSD1 LAMB1 SEZ6L2 ADSL	2.16e-03	261	102	5	C0004352
Disease	Mammary Carcinoma, Human	FN1 TFAP2A CCNE1 JAG2 DKK1 IGFBP5 IGFBP7	2.34e-03	525	102	7	C4704874
Disease	Mammary Neoplasms, Human	FN1 TFAP2A CCNE1 JAG2 DKK1 IGFBP5 IGFBP7	2.34e-03	525	102	7	C1257931
Disease	COVID-19 (is_implicated_in)	A2M CFH	2.38e-03	21	102	2	DOID:0080600 (is_implicated_in)
Disease	systemising measurement	DSCAM ERLEC1	2.38e-03	21	102	2	EFO_0010221
Disease	Mammary Neoplasms	FN1 TFAP2A CCNE1 JAG2 DKK1 IGFBP5 IGFBP7	2.39e-03	527	102	7	C1458155
Disease	sex interaction measurement, bilirubin measurement	COL12A1 FRMD6	2.61e-03	22	102	2	EFO_0004570, EFO_0008343
Disease	Breast Carcinoma	FN1 TFAP2A CCNE1 JAG2 DKK1 IGFBP5 IGFBP7	2.68e-03	538	102	7	C0678222
Disease	alcohol drinking	FAT3 ICE1 TRPM8	2.81e-03	81	102	3	EFO_0004329
Disease	triacylglycerol 54:8 measurement	CNTN4 PTPRT	2.86e-03	23	102	2	EFO_0010426
Disease	apolipoprotein L1 measurement	HPR CPNE1	3.37e-03	25	102	2	EFO_0021854

Protein segments in the cluster

Peptide	Gene	Start	Entry
VSHFYGNGDICDITD	ERLEC1	411	Q96DZ1
YGCRFHSDNFSGEAL	BTNL9	131	Q6UXG8
GSFDCIQQYVSSHGE	ELL	91	P55199
SAEHCLGVQDFGTAY	PRMT9	31	Q6P2P2
SCSEGYHLQAGAEAT	CSMD2	2556	Q7Z408
STLEETYGHCDQNGE	CCDC7	96	Q96M83
HPSFDDYELQSATCG	C6orf120	86	Q7Z4R8
DRGHYVLCDFGSATN	AAK1	186	Q2M2I8
GDTEGEYHRASSENC	AKAP4	141	Q5JQC9
TNTDGSFHCSCEEGY	CD93	401	Q9NPY3
HQFAYVTDGACSGDE	CCNE1	211	P24864
YEDCEDRHDGTSNGT	TFAP2A	11	P05549
DAGSYTCIATNHFGT	CNTN4	471	Q8IWV2
CSDSYHGPSANSEVE	CPA2	271	P48052
CHDGYESNTGSTTGS	CFH	536	P08603
TGDTALTYACENGHT	ANKRD17	596	O75179
DCSQEYTDSTGIDLH	ARPP21	136	Q9UBL0
KYSDASDCHGEDSQA	A2M	271	P01023
FDFYLCSHAGIQGTS	AGO2	746	Q9UKV8
CSINGHSYGDVFDVL	ATP8B2	426	P98198
LAQDYCGDNTTHGTF	MUC5B	921	Q9HC84
YEAGHLENGITESCA	NSD1	1436	Q96L73
GYSGLSCESCDAHFT	HSPG2	736	P98160
DQATGYHFNALTCEG	NR1I3	16	Q14994
FYSSLGCGHSLDNTF	RSPH10B	426	P0C881
FYSSLGCGHSLDNTF	RSPH10B2	426	B2RC85
HCSLEGGSFVTTFDA	MUC6	396	Q6W4X9
EDHGTYTCLAENALG	MYLK	576	Q15746
YCDSQGFHSVPNATD	LRRTM2	46	O43300
LCSDEYFAGGLHSSF	MCPH1	221	Q8NEM0
CTGTSSDVGDYDHVF	IGLV2-33	41	A0A075B6J2
GSHYDNTGFVAEETT	LRRC7	771	Q96NW7
DTCYGDAGSAFAVHD	HPR	291	P00739
SGFTGTYCHENIDDC	JAG2	626	Q9Y219
EYFGLEFCSHSGNNV	FRMD7	41	Q6ZUT3
ASTECFVTDNADGTY	FLNB	1276	O75369
HSGIYSCEADNGLEA	FCRL5	721	Q96RD9
AEHSGNYSCEADNGL	FCRL5	811	Q96RD9
SSSCQSGYEEEAAGL	PDZD8	471	Q8NEN9
VEGNFYSATLAGDHC	PCED1A	211	Q9H1Q7
GSSHDCSSGTYFPEQ	FAM83D	91	Q9H4H8
VTASGDCYTFGSNQH	NEK8	576	Q86SG6
LTFSQASDTCHSYGG	LY75	971	O60449
QNEGICDSYTDFSTG	LAMB1	406	P07942
YVDGDFQCHTFDSSN	IGFBP5	256	P24593
EDAGEYECHASNSQG	IGFBP7	241	Q16270
EEDSSGHTRAYGVCF	MSH6	546	P52701
ECRSGFHDDGTYSLS	NELL1	576	Q92832
FHDDGTYSLSGESCI	NELL1	581	Q92832
QSAAGGCSFDEHYSN	PTPRT	26	O14522
SGTNGEICYTFSHAS	PCDHB11	271	Q9Y5F2
EQEDAGDYTCDTGHT	OBSCN	4041	Q5VST9
HYQCDAGSGSDSESC	PRICKLE3	531	O43900
DFCSTSSFQDSGYNE	FBXO43	66	Q4G163
LATECFQLGYSTDGH	CPT1C	486	Q8TCG5
AQSYTFGCGHELDEE	FRMD6	566	Q96NE9
CDQSSISGPFRDYDH	HSPBAP1	106	Q96EW2
ADSFDTGVYHCISSN	IGSF10	541	Q6WRI0
SCQLGDYSSGDSVSE	ICE1	1181	Q9Y2F5
AAGLTDIFQHDTYCG	CCDC127	206	Q96BQ5
SHCFTGLSPDTDYGV	COL12A1	2256	Q99715
TCQASGDPHYTTFDG	FCGBP	1251	Q9Y6R7
TTCQASGDPHYTTFD	FCGBP	2451	Q9Y6R7
CFDHAAGTSYVVGET	FN1	186	P02751
CQDSETGTFYQIGDS	FN1	561	P02751
ECSGHTSLSFAGNSY	FAT3	3831	Q8TDW7
DGTETHFSIGNHDCY	FAIM	136	Q9NVQ4
FTEYGNCFTFNHGET	ASIC5	201	Q9NY37
TEHSGNYSCEADNGL	FCRL3	536	Q96P31
CDEQLSSQSHYDFGL	DYNC1H1	2076	Q14204
DELGACGHSRTSSYA	FAM102B	196	Q5T8I3
ESFGNDHSTLDGYSR	DKK1	156	O94907
GSAEGCDFSIHFSSF	SEC22C	51	Q9BRL7
NGGCYSELHVEDTTF	SLC15A5	291	A6NIM6
HGSQDGHFVLSCSYD	SCNN1D	416	P51172
ISIGDFGYGHCSSEI	PMS1	411	P54277
FGYGHCSSEISNIDK	PMS1	416	P54277
QCSDYDSDGSHDLIG	CPNE1	211	Q99829
VQSGEDGTEYNFCSS	PNLIPRP2	441	P54317
TGLDTGEYFCTHNDS	PDGFRB	91	P09619
GEYFCTHNDSRGLET	PDGFRB	96	P09619
GQVAYAFDTHTGTDA	OLFML2A	596	Q68BL7
VHDQDSGDNGYTTCF	PCDHGA1	371	Q9Y5H4
GFFSCHAINSYGEDR	DSCAM	861	O60469
QQAGDSDHSETFYEC	RTL1	596	A6NKG5
LNCSVNGSSSYHSDD	URI1	286	O94763
TCDSLDGYHSFECGS	TMEM71	36	Q6P5X7
GNCLEDAAPFSYHST	SCRN2	146	Q96FV2
IHLGATSCYVGDNTD	ADSL	106	P30566
CTDHQDPEGATSSSY	NEO1	1321	Q92859
TGADICGFFNNSEYH	SI	1526	P14410
TATFHCDSGYQLQGE	SEZ6L2	311	Q6UXD5
DHSDYIHLEGSSFCS	SORBS2	606	O94875
SSHDSDCGEVTNYIE	AKAP6	2116	Q13023
ATGDTALTYACENGH	ANKHD1	566	Q8IWZ3
DCHFGDGTLETEQSF	REV3L	896	O60673
HSYSESGASGSSFEE	TEX264	261	Q9Y6I9
YTETGLEFQDGNDSH	TMEM252	126	Q8N6L7
HGSLIYSFSECAFTG	TRIM21	426	P19474
FSIPDTGSHCSSEYA	PMS2	506	P54278
FEYNDSGEDCTHSST	ZNF705B	116	P0CI00
FEYNDSGEDCTHSST	ZNF705D	116	P0CH99
QVSTEGDLYECDSHG	ZNF543	171	Q08ER8
VSGDSLNYGSSLCFH	ZNF544	246	Q6NX49
CGEAFSSSSSFRYHE	ZNF69	511	Q9UC07
AHCFETYSDLSDPSG	PRSS21	81	Q9Y6M0
SEEAGQFIYNGFCSH	TESPA1	76	A2RU30
SRGTYIGCFSDDGHE	WSCD1	141	Q658N2
PSDVDGTTYDFAHCT	TRPM8	916	Q7Z2W7
GTTYDFAHCTFTGNE	TRPM8	921	Q7Z2W7
LEGEDVGACTAHTYS	UBR2	1651	Q8IWV8
QGHTDGASCIDISDY	TLE2	586	Q04725
YHENDSSSEGDNDSG	PJA1	466	Q8NG27
TTEGSYEDVQCFSGE	TG	621	P01266
DTVSGSIYEDSCASH	KIAA0586	1371	Q9BVV6
CDSSGNSFAVTGYDL	WDR54	311	Q9H977
CSDSSSLGDDGYHTE	ZBTB34	246	Q8NCN2
YGENSGTHVGSFSCS	PRO0461	6	Q9UI25
HCGYTQLSPFSEDSA	USP54	596	Q70EL1